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ABSTRACT
Inhaled medication is typically used to treat obstructive pulmonary disease and 
systemic diseases. The effectiveness of pulmonary drug delivery depends on the 
amount of drug deposited beyond the oropharyngeal region, the place where the 
deposition and the uniform distribution occurred. In this study, the performance of 
multistage liquid impinger (MSLI) simplified model which imitates the physiological 
lung in delivering the drug was analyzed. In order to achieve this main aim, the airflow 
patterns and particle depositions efficiency were evaluated in MSLI simplified model 
using computational fluid dynamic o f COMSOL® software. The particle deposition 
efficiency is studied by varying flowrates (30.0 L/min, 60.0 L/min and 100.0 L/min) 
and particle sizes (0.1, 1.0, 3.0, 5.0, 10.0 pm) of salbutamol sulphate (density 20.0 
kg/m3). The highest particle deposition occurred at flowrate 100.0 L/min and particle 
size of 1.0 pm as the deposition yield was 15.55% compared to flowrate 60 L/min and
30 L/min which were 10.50% and 3.09% respectively. Previous studies claimed that 
higher inhalation flowrate generated dispersion forces for sufficient inhalation 
flowrate thus enhanced higher deposition efficiency. The paired-samples T-test shows 
there were significant different (t= -15.400, df= 4, p <0.05) in the performance of 
particle depositions in MSLI simplified model with different flow rates (60.0 L/min 
and 100.0 L/min). Thus, the efficient fine particle deposition was significantly 
contributed by higher flowrate. This study also revealed that particle size ranges from
1.0 to 3.0 pm was the most suitable for inhalation treatment. Smaller particle size less 
than 1.0 pm was not suitable as it tended to exhale before it deposit of while larger 
particle (more than 5.0 pm) was not suitable for inhaled drug. In conclusion, vigorous 
air flow pattern promotes higher particle deposition. For efficient fine particle 
depositions, it is important to consider not only the particle size distribution, but also 
the flowrate as vital aerosol transportation agent. Statistical analysis, two-way 
ANOVA indicated that there was a statistically significant interaction between the 




Ubat sedutan kebiasaanya digunakan untuk merawat penyakit kronik 
pulmonari dan penyakit sistemik. Keberkesanan penghantaran ubat pulmonari 
bergantung kepada jumlah ubat yang termendap menjangkaui kawasan orofaring, 
tempat di mana pemendapan dan tabur seragam berlaku. Dalam kajian ini, prestasi 
model mudah cawangan cecair pelbagai peringkat yang menyerupai fisiologi paru- 
paru dalam penghantaran ubat telah dianalisa. Untuk mencapai matlamat utama ini, 
corak aliran udara dan kecekapan pemendapan zarah telah dikaji dalam model mudah 
MSLI menggunakan pengiraan dinamik bendalir iaitu melalui perisian COMSOL®. 
Kecekapan pemendapan zarah dikaji dengan perbezaan kadaralir (30.0 L/min, 60 
L/min dan 100 L/min) serta berlainan saiz zarah (0.1, 1.0, 3.0, 5.0, 10.0 pm) 
salbutamol sulfat (ketumpatan 20 kg/m3). Pemendapan zarah tertinggi berlaku pada 
aliran 100 L/min dan pada saiz zarah 1.0 pm dengan hasil mendapan 15.55%, 
berbanding dengan kadaralir 60 L/min dan 30 L/min iaitu masing-masing 10.50% dan 
3.09%. Kajian terdahulu menyatakan kadaralir pernafasan yang tinggi menjana daya 
penyebaran kadaralir pernafasan yang mencukupi dan meningkatkan kecekapan 
pemendapan. Ujian-T-sampel berpasangan menunjukkan terdapat perbezaan yang 
ketara (t=-15.400, df=4, p<0.05) dalam prestasi pemendapan zarah dalam model 
mudah MSLI dengan kadaralir yang berlainan (60 L/min dan 100 L/min). Oleh itu, 
keberkesanan pemendapan zarah halus adalah penting disumbang oleh kadaralir yang 
tinggi. Kajian ini juga menunjukkan bahawa julat saiz zarah dari 1.0 hingga 3.0 pm 
adalah yang paling sesuai untuk rawatan pernafasan. Saiz zarah yang kecil kurang dari
1.0 pm tidak sesuai kerana ia cenderung terhembus keluar sebelum dapat mendap 
manakala zarah yang besar (lebih daripada 5.0 pm) tidak sesuai untuk ubat sedutan. 
Sebagai kesimpulan, corak aliran udara yang kuat menggalakkan pemendapan zarah 
yang tinggi. Bagi pemendapan zarah halus yang cekap, adalah perlu untuk 
mengambilkira bukan sahaja pengedaran saiz zarah, tetapi juga kadaralir sebagai ejen 
pengangkutan zarah yang penting. Analisis statistik, dua hala ANOVA menunjukkan 
terdapat interaksi ketara secara statistik antara kesan kadaralir dan saiz zarah ke atas 
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Inhaled drug therapy has gained extensive acceptance and has been used a long 
time ago as an effective non-invasive alternative for local and systemic medicine 
delivery o f active pharmaceutical ingredients (APIs) (L. Chen, Okuda, Lu, and Chan, 
2016; Kolanjiyil and Kleinstreuer, 2016). It does not only treat ‘traditional diseases’ 
such as asthma and other pulmonary disease, but it also capable to treat other systemic 
diseases like diabetes, migraine, angina pectoris, kidney failure, cancer, bone 
disorders, acute lung injury, tuberculosis due to an advancement in analysis technology 
(Lalas et al., 2017).
This route of drug delivery has many advantages compared to other non- 
invasive administration methods such as an oral, buccal, trans-dermal, vaginal, nasal 
or ocular administration as it allows the use of lesser doses and lower systemic side 
effects (Kolanjiyil & Kleinstreuer, 2016; Labiris & Dolovich, 2003 a). This treatment 
also provides rapid absorption of the inhaled drug aerosol, especially nano-drugs due 
to unique features of lungs including highly vascularized surface area (80-100.0 m2 for 
adult with 5.0 L/min blood flow) and thin alveolar-capillary membrane (0.1-0.5^m), 
low enzymatic activity (L. Chen et al., 2016; Depreter and Amighi, 2010), and result 
in rapid bio-distribution when targeting diseased organs (Kolanjiyil & Kleinstreuer, 
2016). In addition, this treatment method allows systemic drug delivery without liver 
passage due to low metabolic activity in the lungs, thus avoiding first-pass metabolism 
in the liver. Hence, the lung provides a favourable environmental condition for 
therapeutic drugs and avoids for enzymatic and hepatic degradation in the 
gastrointestinal tract (Lalas et al., 2017).
For the past decade, investigations have been done to measure the inhaled 
drugs deposition in the human respiratory airways. Unlike in vivo experimental that 
using a whole or living organism in laboratory procedure only offer total or surface 
deposition data, mathematical simulations provide more meticulous information in 
terms of space and time which experimental observation fails to provide (Phuong & 
Ito, 2015). The most common mathematical modelling that applies to forecast fluid 
flow inside a system is Computational Fluid Dynamics (CFD). CFD can predict the 
deposition fraction and flow structure of the respiratory system (Saber and Heydari,
2012). Fluid flow characteristics can be determined by changing one or more input 
airflow parameters. Moreover, numerical simulation also permits study of different 
flow variables and forces of fluid flow in a specifics perspective (Rahimi-Gorji, 
Pourmehran, Gorji-Bandpy, & Gorji, 2015).
1.2 Problem Statement
It is challenging to capture the particle deposition for the entire pulmonary 
airways because of the complex structure of the lungs (Kolanjiyil & Kleinstreuer, 
2013). Recent lung airway models are only restricted to the few upper airway 
generations. Due to limited resources of imaging technology and tiny branching 
structure of alveoli, lower part of airways are the hardest part to reconstruct (Lin, 
Tawhai, & Hoffman, 2013). Since it is difficult to simulate the three-dimensional (3­
D) aerosol deposition for the whole lung airways, researcher has come out with 
simplified configuration as an alternative solution to overcome the limitation of 
computational o f real lung geometry (Hansen & Ampaya, 1975; Horsfield & 
Cumming, 1968; Yeh & Schum, 1980). Simplified model which imitate the structure 
of human lung are easy implementation and low requirements of computational 
resources (Kolanjiyil & Kleinstreuer, 2016) and it has tendency to satisfy specific 
modelling requirement which can cover all 23 -generation of lung airways that real 
human lung does not (Hofmann, 2011).
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In laboratory procedure, it is difficult to obtain the detailed information of air 
behaviour or particle transport, local deposition patterns and surface densities of 
particle deposited in branching airways (Z Zhang, Kleinstreuer, & Kim, 2002). In vivo 
studies of aerosol deposition in the human lungs are also limited to human safety and 
by resolution limitation of current imaging technologies. In additions there were no 
clear studies that had been reported on the unsteady inhalation patterns and steady flow 
rates in pulmonary drug deposition analysis (Inthavong, Tu, & Heschl, 2011). The 
computed deposition also produced unpredicted result as the study was conducted 
based on simple inlet conditions and semi-analytical correlations for the deposition 
mechanisms (Hofmann, 2011).
Therefore, CFD simulation can fill the gap to achieve the deposition fraction 
and flow structure of the respiratory system (Saber & Heydari, 2012; Z Zhang et al., 
2002) and provide unprecedented level of detail which experiment data cannot provide 
(Koullapis, Kassinos, Bivolarova, & Melikov, 2016). Furthermore, for every 
experimental data set it is important to validate the data using computer simulation 
models and gaining new physical perception, thus by applied CFD simulation can offer 
more detailed, accurate particle deposition studies with development of efficient, cost 
effective, and as an important component in industrial, academic research and 
preliminary design of a new product (Zhe Zhang, Kleinstreuer, & Kim, 2009).
Multi Stage Liquid Impinger (MSLI) is the most accurate impactor in 
evaluating the particle deposition of Dry Powder Inhaler (DPIs) in pharmaceutical 
industry. The system is compatible with human respiratory function as it consists five 
stages including filter, operates between air flowrate of 30.0 and 100.0 L/min and able 




The main aim of the study is to analyse the performance of MSLI which imitate 
the physiological lung in delivering the drug. In order to achieve the aim, two 
objectives are set as follows:
i. To determine airflow patterns in the Multistage Liquid Impinger 
(MSLI) simplified model.
ii. To analyse particle depositions in the Multistage Liquid Impinger 
(MSLI) simplified model.
1.4 Scope of Study
The scopes of this study are:
i. To use the SOLIDWORK® software as a tool to develop the MSLI 
simplified model.
ii. To analyse the air flow patterns and particles deposition in MSLI 
simplified model by applying differences variables of particle sizes and 
air flow rate using COMSOL® software.
iii. The study done on modelling o f the MSLI simplified model and does 
not covered the experimental works.
1.5 Significance of Study
Since many challenges in modelling human respiratory airway due to its 
complex structure and limited resources of imaging technology, thus a simplified 
model o f MSLI which imitate the human lungs structure was implement in this study.
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It is easy to implement because MSLI simplified model requires low computational 
resources and most importantly, it represents all 23-generation of lungs airways that 
human lungs model does not applied (Kolanjiyil & Kleinstreuer, 2013).
This is the first attempt to model the industrial pharmaceutical device o f MSLI 
simplified model which is an accurate impactor that evaluates the particle deposition 
of DPIs in pharmaceutical industry. The system in MSLI is compatible with human 
respiratory function as it consist five stages including filter which can imitate the 
function of alveolus that filter the blood in human lungs. It operates between air 
flowrate of 30.0 L/min and 100.0 L/min indicating different human lungs activity and 
able to filter particles between 1.7 and 13.0 micron in the different of MSLI stages 
(Jolyon P. Mitchell & Nagel, 2003).
In laboratories procedures, there were no clear studies regarding the unsteady 
inhalation patterns and steady flow rates in pulmonary drug deposition analysis, 
especially in pharmaceutical industry device (Inthavong et al., 2011). Thus, CFD 
simulation in MSLI allow to capture the condition inside that model, the flow structure 
and deposition fraction thus produce detail insight flow the real respiratory system 
which experiment data cannot provided (Saber & Heydari, 2012; Z Zhang et al., 2002).
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